ATE283063T1 - Allogene und xenogene transplantation - Google Patents

Allogene und xenogene transplantation

Info

Publication number
ATE283063T1
ATE283063T1 AT99121033T AT99121033T ATE283063T1 AT E283063 T1 ATE283063 T1 AT E283063T1 AT 99121033 T AT99121033 T AT 99121033T AT 99121033 T AT99121033 T AT 99121033T AT E283063 T1 ATE283063 T1 AT E283063T1
Authority
AT
Austria
Prior art keywords
administering
xenogene
allogene
transplantation
short course
Prior art date
Application number
AT99121033T
Other languages
English (en)
Inventor
David H Sachs
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE283063T1 publication Critical patent/ATE283063T1/de

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99121033T 1993-05-17 1994-05-16 Allogene und xenogene transplantation ATE283063T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6317193A 1993-05-17 1993-05-17
US12960893A 1993-09-29 1993-09-29
US18155894A 1994-01-12 1994-01-12
US22037194A 1994-03-29 1994-03-29

Publications (1)

Publication Number Publication Date
ATE283063T1 true ATE283063T1 (de) 2004-12-15

Family

ID=27490346

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99121033T ATE283063T1 (de) 1993-05-17 1994-05-16 Allogene und xenogene transplantation
AT94918019T ATE253378T1 (de) 1993-05-17 1994-05-16 Xenogene transplantation

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT94918019T ATE253378T1 (de) 1993-05-17 1994-05-16 Xenogene transplantation

Country Status (6)

Country Link
EP (1) EP0699073B1 (de)
JP (2) JPH09500616A (de)
AT (2) ATE283063T1 (de)
AU (1) AU688330B2 (de)
CA (1) CA2162496A1 (de)
DE (2) DE69434159T2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU673987C (en) * 1991-11-22 2005-02-17 General Hospital Corporation, The Specific tolerance in transplantation
AU6268194A (en) * 1994-02-14 1995-08-29 General Hospital Corporation, The Stem cell engraftment

Also Published As

Publication number Publication date
EP0699073B1 (de) 2003-11-05
JPH09500616A (ja) 1997-01-21
JP2006312647A (ja) 2006-11-16
DE69433298D1 (de) 2003-12-11
CA2162496A1 (en) 1994-11-24
DE69433298T2 (de) 2004-08-26
AU688330B2 (en) 1998-03-12
AU6952194A (en) 1994-12-12
DE69434159D1 (de) 2004-12-30
ATE253378T1 (de) 2003-11-15
HK1029512A1 (en) 2001-04-06
EP0699073A4 (de) 1997-09-10
EP0699073A1 (de) 1996-03-06
DE69434159T2 (de) 2005-12-01

Similar Documents

Publication Publication Date Title
ATE395418T1 (de) Alpha(1,3)galactosyltransferase-negatives schwein
GR3036778T3 (en) -i(IN VITRO) CORNEA EQUIVALENT MODEL.
DE69521406D1 (de) Apparat und verfahren zur herstellung fester formen mit gesteuerter freisetzung des wirkstoffs
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
FI972093A0 (fi) Jäteveden käsittelymenetelmä ja -laitos
NO942351D0 (de)
ATE193550T1 (de) Rekonstruiertes knorpelgewebe
ZA951292B (en) 4-amino derivatives of mycophenolic acid
IS4100A (is) Aðferð við meðhöndlun á ígræðlingi úr málmi fyrirskurðaðgerð
DE69907945D1 (de) Zusammensetzung zur vorbeugung und/oder behandlung der atherosklerose
DE69202019D1 (de) Verwendung von essentiellen Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von AIDS.
DE60231522D1 (de) Behandlung und vorbeugung von insulin-produzierende zelltransplantatabstossung
ATE464910T1 (de) Humane cd80-mutante und zusammensetzungen und methoden zu deren herstellung und verwendung
SE9003718D0 (sv) Implantat med genomgaaende passage
DE69633393D1 (de) Mitteln zur behandlung von auto-immun krankheiten
ATE238990T1 (de) Pyridylthioverbindungen zur bekämpfung von helicobacter-bakterien
DK0768886T3 (da) Endothelforingseffekter og behandling af vasospastiske lidelser
ATE234614T1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE146967T1 (de) Verwendung von ifn-gamma zur behandlung von infektionen bei transplantatenempfängern
ATE253378T1 (de) Xenogene transplantation
DK0745071T3 (da) 4-Amino-6-substitueret mycophenolsyre og derivater med immunsuppressiv virkning
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
SE8306424D0 (sv) Forfarande for avlegsnande av immunkomplex ur blod och immobiliserat pepsin for genomforande av forfarandet
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties